These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35467293)

  • 1. A Historical Perspective on the Dopamine D3 Receptor.
    Sokoloff P; Le Foll B
    Curr Top Behav Neurosci; 2023; 60():1-28. PubMed ID: 35467293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bitropic D3 Dopamine Receptor Selective Compounds as Potential Antipsychotics.
    Luedtke RR; Rangel-Barajas C; Malik M; Reichert DE; Mach RH
    Curr Pharm Des; 2015; 21(26):3700-24. PubMed ID: 26205291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors.
    Schmieg N; Rocchi C; Romeo S; Maggio R; Millan MJ; Mannoury la Cour C
    J Neurochem; 2016 Mar; 136(5):1037-51. PubMed ID: 26685100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [
    Slifstein M; Abi-Dargham A; Girgis RR; Suckow RF; Cooper TB; Divgi CR; Sokoloff P; Leriche L; Carberry P; Oya S; Joseph SK; Guiraud M; Montagne A; Brunner V; Gaudoux F; Tonner F
    Psychopharmacology (Berl); 2020 Feb; 237(2):519-527. PubMed ID: 31773210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors.
    McCormick PN; Wilson VS; Wilson AA; Remington GJ
    Pharmacol Res; 2013 Apr; 70(1):66-71. PubMed ID: 23327779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.
    Zhang W; Bymaster FP
    Psychopharmacology (Berl); 1999 Jan; 141(3):267-78. PubMed ID: 10027508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacology of antipsychotics at human dopamine D2 and D3 receptors].
    Tadori Y; Kikuchi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Feb; 32(1):9-18. PubMed ID: 22568121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways.
    Taylor M; Grundt P; Griffin SA; Newman AH; Luedtke RR
    Synapse; 2010 Mar; 64(3):251-66. PubMed ID: 19924694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining dopamine D3 receptor occupancy by antipsychotic drugs via [3H]7-OH-DPAT ex vivo autoradiography and its cross-validation via c-fos immunohistochemistry in the rat brain.
    Davoodi N; te Riele P; Langlois X
    Eur J Pharmacol; 2014 Oct; 740():669-75. PubMed ID: 24967534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.
    Mahmoudi S; Lévesque D; Blanchet PJ
    Mov Disord; 2014 Aug; 29(9):1125-33. PubMed ID: 24838395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds.
    Luedtke RR; Mishra Y; Wang Q; Griffin SA; Bell-Horner C; Taylor M; Vangveravong S; Dillon GH; Huang RQ; Reichert DE; Mach RH
    ACS Chem Neurosci; 2012 Dec; 3(12):1050-62. PubMed ID: 23259040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis.
    Ducasse D; Boyer L; Michel P; Loundou A; Macgregor A; Micoulaud-Franchi JA; Courtet P; Abbar M; Leboyer M; Fond G
    Psychopharmacology (Berl); 2014 Sep; 231(18):3765-70. PubMed ID: 24599398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO.
    Tateno A; Sakayori T; Kim WC; Honjo K; Nakayama H; Arakawa R; Okubo Y
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):522-527. PubMed ID: 29346639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo.
    Beaulieu JM; Tirotta E; Sotnikova TD; Masri B; Salahpour A; Gainetdinov RR; Borrelli E; Caron MG
    J Neurosci; 2007 Jan; 27(4):881-5. PubMed ID: 17251429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of probes for PET imaging of dopamine D3 receptors.
    Doot RK; Dubroff JG; Labban KJ; Mach RH
    Neurosci Lett; 2019 Jan; 691():18-25. PubMed ID: 29518538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
    Gurevich EV; Bordelon Y; Shapiro RM; Arnold SE; Gur RE; Joyce JN
    Arch Gen Psychiatry; 1997 Mar; 54(3):225-32. PubMed ID: 9075463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
    Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
    Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The dopamin D3 receptor--the gray eminence of pharmacotherapy?].
    Sumegi A; Varga E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):405-11. PubMed ID: 20962360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature.
    Stone JM; Davis JM; Leucht S; Pilowsky LS
    Schizophr Bull; 2009 Jul; 35(4):789-97. PubMed ID: 18303092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D3 Receptors: From Bench to Bedside.
    Gonda X; Tarazi FI
    Neuropsychopharmacol Hung; 2021 Jun; 23(2):272-280. PubMed ID: 34342419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.